Beijing Biomarker Technologies Co., Ltd.
PrivateLast Round
Growth Equity
Jun 29, 2020
Total Funding Raised
$112.9M
Company Overview
Beijing Biomarker Technologies Co., Ltd. is a biotechnology company that provides gene multi-omics sequencing services, bioinformatics analysis, and develops single-cell and spatial omics instruments for scientific research, breeding, and medical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Biomarker Technologies Co., Ltd. Comparables
Compare Beijing Biomarker Technologies Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Majorbio Bio-pharm Technology Co., Ltd. | 91% | |
| Shanghai Personal Biotechnology Co., Ltd. | 89% | |
| Annoroad Gene Technology | 87% |
Beijing Biomarker Technologies Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jun 29, 2020 | ||||
| Series A | Dec 29, 2015 |
Beijing Biomarker Technologies Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Alliance Capital | Growth Equity |
| Red Horse Investment Group | Growth Equity |
| Lang Sheng Investment | Series A |
| Sinopec Capital Co., Ltd. | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2026
Grew 33% QoQ, from 27 to 36 employees.
- Oct 13, 2025
Grew 19% QoQ, from 26 to 31 employees.
Beijing Biomarker Technologies Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing Biomarker Technologies Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Biomarker Technologies Co., Ltd. a public or private company?
Beijing Biomarker Technologies Co., Ltd. is a private company.
What is the current stock price of Beijing Biomarker Technologies Co., Ltd.?
Beijing Biomarker Technologies Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Beijing Biomarker Technologies Co., Ltd. worth (valuation)?
Valuation information for Beijing Biomarker Technologies Co., Ltd. is not publicly available.
Can I buy Beijing Biomarker Technologies Co., Ltd. stock?
Beijing Biomarker Technologies Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing Biomarker Technologies Co., Ltd.'s last funding round?
Beijing Biomarker Technologies Co., Ltd.'s most recent funding round was Growth Equity on June 29, 2020.
Who are the main investors in Beijing Biomarker Technologies Co., Ltd.?
Key investors in Beijing Biomarker Technologies Co., Ltd. include Lang Sheng Investment.
Will Beijing Biomarker Technologies Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Biomarker Technologies Co., Ltd..
How can I track Beijing Biomarker Technologies Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Biomarker Technologies Co., Ltd.'s secondary market activity and sign up for updates.